To determine the effect of Notch signaling inhibitor DBZ on Ang II-induced AAA formation, Ang II-infused Apo E-/- mice were treated subcutaneously with DBZ (1 mg/kg/d) or vehicle for 4 weeks. The gene discussed is AGT; the disease is triple-A syndrome.